Page last updated: 2024-08-21

pyrazines and mitomycin

pyrazines has been researched along with mitomycin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Dwyer, PJ; Yao, KS1
Hall, EJ; Hei, TK; Liu, SX1
Cassidy, J; Hochster, H1

Reviews

1 review(s) available for pyrazines and mitomycin

ArticleYear
New oxaliplatin-based combinations in the treatment of colorectal cancer.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2003, Volume: 5 Suppl 3

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Boronic Acids; Bortezomib; Camptothecin; Capecitabine; Cetuximab; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Gefitinib; Humans; Irinotecan; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Pyrazines; Quinazolines; Thiophenes

2003

Other Studies

2 other study(ies) available for pyrazines and mitomycin

ArticleYear
Involvement of NF-kappa B in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C.
    Biochemical pharmacology, 1995, Jan-31, Volume: 49, Issue:3

    Topics: Anticarcinogenic Agents; Base Sequence; Cell Hypoxia; Enzyme Induction; Humans; Mitomycin; Molecular Sequence Data; NAD(P)H Dehydrogenase (Quinone); NF-kappa B; Protein Binding; Pyrazines; Signal Transduction; Thiones; Thiophenes; Tumor Cells, Cultured

1995
Oncogenic potential of bifunctional bioreductive drugs.
    The British journal of cancer. Supplement, 1996, Volume: 27

    Topics: Animals; Antineoplastic Agents; Aziridines; Cell Survival; Cell Transformation, Neoplastic; Indolequinones; Indoles; Mice; Mice, Inbred C3H; Mitomycin; Oxidation-Reduction; Pyrazines; Structure-Activity Relationship

1996